Best Peptides for Sleep

No peptide is proven to work like a sleeping pill. DSIP, the peptide named for deep sleep, showed only weak effects in a controlled trial of people with chronic insomnia. For women over 40, the peptides worth asking about are growth hormone releasers such as sermorelin, ipamorelin and CJC-1295. They work on the growth hormone pulse your body releases in deep sleep, a rhythm that shifts after menopause. They fit best when better sleep is part of a bigger energy and aging goal.

Does DSIP work for sleep?

DSIP has the best name and the weakest case. DSIP stands for delta sleep-inducing peptide. In a double-blind study of 16 people with chronic insomnia, three nights of IV DSIP slightly shortened how long people took to fall asleep and slightly increased how much of the night they spent asleep. The researchers called these effects weak, partly because of a chance change in the placebo group. People did not feel they slept any better. The researchers concluded that short-term DSIP is unlikely to be of major benefit.

The hopeful DSIP result comes from an older open study with no placebo group. Seven people with severe insomnia got 10 injections. Sleep returned to normal in six of them, and stayed that way through 3 to 7 months of follow-up. Their daytime mood and performance improved too. Without a comparison group, it is hard to know how much of that came from DSIP.

DSIP also has a practical problem. It breaks down within minutes in the fluid around the brain, which makes it hard to use as a treatment. It was never officially approved and circulates only as a research peptide. The World Anti-Doping Agency prohibits it.

FDA says it does not have enough information to know whether compounded DSIP (listed as emideltide) would cause harm in humans. It says DSIP may provoke an immune reaction, and it has not found safety information for the proposed route. The nomination to compound DSIP was withdrawn.

Why does my sleep change after 40, and what do peptides have to do with it?

Your sleep can look the same on paper while the hormone rhythm underneath it shifts. Your body releases a pulse of growth hormone soon after you drop into deep sleep, also called slow wave sleep. In a study of 35 women, postmenopausal women slept as long as premenopausal women and spent the same share of the night in each sleep stage. But their first growth hormone peak after falling asleep came later and at less predictable times. The link between growth hormone and deep sleep was weaker after menopause.

The same researchers restudied the postmenopausal women after six months of hormone therapy or placebo. Hormone therapy did not change how their deep sleep was spread across the night, and it did not bring back the link between growth hormone and deep sleep. Estrogen alone does not explain the whole change.

A separate study gave small doses of growth hormone releasing peptides to 20 premenopausal women (average age 24) and 22 postmenopausal women (average age 63). Three things each shaped the size of their growth hormone pulses:

• being premenopausal rather than postmenopausal
• having estrogen restored
• which type of peptide was used (a ghrelin-type peptide called GHRP-2 produced larger pulses than a peptide copying growth hormone releasing hormone)

That is why we treat sleep peptides as a growth hormone question rather than a sedative question. They work on your nighttime pulse. They are not a knockout drug.

Sermorelin, ipamorelin or CJC-1295: which one fits my goal?

Sermorelin, ipamorelin and CJC-1295 are part of Hot or Nothing's plans. All three work on the growth hormone pulse. The research below measures growth hormone. It does not measure how well women slept.

Some of these peptides come with FDA safety notes. Your clinical team weighs them against your history.

For CJC-1295, FDA has reported serious side effects, including a faster heart rate and a body-wide reaction where blood vessels widen. FDA says clinical data are limited and that your immune system may react to the peptide.

FDA has listed ipamorelin acetate in category 2 for outsourcing facilities (503B) since September 29, 2023. That is its group for bulk substances that may present significant safety risks. FDA points to a published study in which ipamorelin given by IV for gut motility was linked to serious adverse events, including death. It says it lacks information on harm through certain other injectable routes, and that ipamorelin may also provoke an immune reaction. Ask your clinical team what to watch for with whichever peptide they choose.

Your clinical team decides whether one of these fits your goal and health history.

Which sleep peptides should I skip?

Skip DSIP, MK-677 and the habit of piling on products. DSIP is covered above.

MK-677 (ibutamoren) is a pill that raises growth hormone. FDA lists it in category 2 for both compounding pharmacies (503A, since September 29, 2023) and outsourcing facilities (503B, since December 29, 2022). It did so because of the potential for congestive heart failure, after a hip fracture trial ended early over a possible heart failure signal.

In a four-day study of nine men with growth hormone deficiency, MK-677 raised growth hormone in every man. Fasting insulin, insulin after meals and blood sugar after meals also went up significantly. The authors said longer use might bring some glucose intolerance, which still needs study.

Taking many products at once can backfire, and it makes it impossible to tell what is helping. One Reddit user taking DSIP alongside many other peptides wrote: "most days I feel tired but wired. Brain never slows down." The same user also wrote: "I wake all through the night. From 1-4 times."

Growth hormone releasing peptides as a group bring modest gains in lean mass and performance and can carry metabolic risks such as insulin resistance. Tell your clinical team about any blood sugar history.

How do I pick the right sleep peptide for me?

1. Name your real goal. If you only want to fall asleep tonight, these peptides are not a sleeping pill. A growth hormone peptide is worth asking about if you want more energy, a body that recovers better and deeper nights as you age.
2. Tell your clinical team where you are in perimenopause or menopause. After menopause, your first growth hormone peak after falling asleep comes later and less predictably, and its link to deep sleep weakens.
3. Start with one treatment your clinical team chooses, not a pile of products, so you can tell what changed.
4. Track how you sleep and how you feel in the afternoon for a few weeks. Bring those notes to your follow-up.

Take the quiz so your clinical team can look at your sleep, your stage of menopause and your energy goals, and decide whether sermorelin, ipamorelin or CJC-1295 belongs in your plan.